Equifax Inc. (NYSE:EFX – Get Free Report) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 2,880,000 shares, a decrease of 7.7% from the March 15th total of 3,120,000 shares. Based on an average daily volume of 759,400 shares, the short-interest ratio is presently 3.8 days.
Institutional Trading of Equifax
A number of hedge funds and other institutional investors have recently made changes to their positions in EFX. Tobam grew its position in Equifax by 37.2% during the fourth quarter. Tobam now owns 568 shares of the credit services provider’s stock valued at $140,000 after buying an additional 154 shares during the period. Turtle Creek Wealth Advisors LLC acquired a new stake in Equifax during the fourth quarter valued at $41,000. Parnassus Investments LLC grew its position in Equifax by 38.8% during the third quarter. Parnassus Investments LLC now owns 113,315 shares of the credit services provider’s stock valued at $20,757,000 after buying an additional 31,686 shares during the period. Tower Research Capital LLC TRC grew its position in Equifax by 243.0% during the third quarter. Tower Research Capital LLC TRC now owns 11,181 shares of the credit services provider’s stock valued at $2,048,000 after buying an additional 7,921 shares during the period. Finally, Premier Path Wealth Partners LLC acquired a new stake in Equifax during the fourth quarter valued at $1,240,000. Institutional investors and hedge funds own 96.20% of the company’s stock.
Equifax Stock Performance
Shares of NYSE EFX traded down $4.37 during midday trading on Tuesday, reaching $238.55. The company had a trading volume of 1,058,410 shares, compared to its average volume of 776,154. The business’s 50-day simple moving average is $259.23 and its 200 day simple moving average is $231.00. The stock has a market cap of $29.64 billion, a P/E ratio of 54.22, a P/E/G ratio of 1.94 and a beta of 1.51. Equifax has a 1 year low of $159.95 and a 1 year high of $275.10. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.04.
Equifax Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, February 23rd were paid a $0.39 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.65%. Equifax’s payout ratio is currently 35.45%.
Analysts Set New Price Targets
EFX has been the subject of several research reports. TheStreet raised shares of Equifax from a “c+” rating to a “b-” rating in a research report on Friday, December 29th. Oppenheimer upped their price target on shares of Equifax from $273.00 to $291.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 9th. The Goldman Sachs Group upped their price target on shares of Equifax from $195.00 to $222.00 and gave the stock a “neutral” rating in a research report on Friday, December 29th. Bank of America raised shares of Equifax from an “underperform” rating to a “buy” rating and upped their price target for the stock from $164.00 to $300.00 in a research report on Monday, January 8th. Finally, Truist Financial upped their price target on shares of Equifax from $270.00 to $285.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $267.00.
Get Our Latest Research Report on EFX
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Further Reading
- Five stocks we like better than Equifax
- What is the Shanghai Stock Exchange Composite Index?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Technology Stocks Explained: Here’s What to Know About Tech
- Undervalued UnitedHealth Group Won’t Be For Long
- 3 Grocery Stocks That Are Proving They Are Still Essential
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.